申请人:Pfizer Inc.
公开号:US05504095A1
公开(公告)日:1996-04-02
Aminobenzosultam derivatives, which are inhibitors of lipoxygenase, having the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein Ar is cycloalkyl having five to seven carbon atoms, tetrahydropyranyl, pyridyl, oxazolyl, phenyl or substituted phenyl wherein said substituent is methyl, methoxy, fluoro, chloro or trifluoromethyl; n is an integer of 1 to 3; X is hydrogen, methyl, methoxy, fluoro, chloro or trifluoromethyl; Z is --NH--, --O--, or --CH.sub.2 --; and R.sup.1 is hydrogen or alkyl having one to three carbon atoms.
氨基苯磺酰胺衍生物是脂氧化酶抑制剂,具有以下结构式##STR1##及其药用酸盐,其中Ar为含有五至七个碳原子的环烷基、四氢吡喃基、吡啶基、噁唑基、苯基或取代苯基,所述取代基为甲基、甲氧基、氟、氯或三氟甲基;n为1至3的整数;X为氢、甲基、甲氧基、氟、氯或三氟甲基;Z为--NH--、--O--或--CH.sub.2 --;R.sup.1为氢或含有一至三个碳原子的烷基。